Literature DB >> 23746975

Modeling human disease with pluripotent stem cells: from genome association to function.

Florian T Merkle1, Kevin Eggan.   

Abstract

Mechanistic insights into human disease may enable the development of treatments that are effective in broad patient populations. The confluence of gene-editing technologies, induced pluripotent stem cells, and genome-wide association as well as DNA sequencing studies is enabling new approaches for illuminating the molecular basis of human disease. We discuss the opportunities and challenges of combining these technologies and provide a workflow for interrogating the contribution of disease-associated candidate genetic variants to disease-relevant phenotypes. Finally, we discuss the potential utility of human pluripotent stem cells for placing disease-associated genetic variants into molecular pathways.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23746975     DOI: 10.1016/j.stem.2013.05.016

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  88 in total

1.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

2.  Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy.

Authors:  Yingxin Li; Karim Sallam; Peter J Schwartz; Joseph C Wu
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-06

Review 3.  Toward pluripotency by reprogramming: mechanisms and application.

Authors:  Tao Wang; Stephen T Warren; Peng Jin
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

4.  Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.

Authors:  Florian T Merkle; Werner M Neuhausser; David Santos; Eivind Valen; James A Gagnon; Kristi Maas; Jackson Sandoe; Alexander F Schier; Kevin Eggan
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 5.  Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.

Authors:  Ling Liu; Jin-Sha Huang; Chao Han; Guo-Xin Zhang; Xiao-Yun Xu; Yan Shen; Jie Li; Hai-Yang Jiang; Zhi-Cheng Lin; Nian Xiong; Tao Wang
Journal:  Mol Neurobiol       Date:  2015-12-10       Impact factor: 5.590

6.  Generation of CD44 gene-deficient mouse derived induced pluripotent stem cells: CD44 gene-deficient iPSCs.

Authors:  Zhenwei Song; Qianqian Ji; Haijing Zhao; Yu Nie; Zuyong He; Yaosheng Chen; Peiqing Cong
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-21       Impact factor: 2.416

7.  Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.

Authors:  Julio Cesar Aguila; Alexandra Blak; Joris van Arensbergen; Amaia Sousa; Nerea Vázquez; Ariane Aduriz; Mayela Gayosso; Maria Paz Lopez Mato; Rakel Lopez de Maturana; Eva Hedlund; Kai-Christian Sonntag; Rosario Sanchez-Pernaute
Journal:  Stem Cells Transl Med       Date:  2014-07-14       Impact factor: 6.940

8.  Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes.

Authors:  Yves Maury; Julien Côme; Rebecca A Piskorowski; Nouzha Salah-Mohellibi; Vivien Chevaleyre; Marc Peschanski; Cécile Martinat; Stéphane Nedelec
Journal:  Nat Biotechnol       Date:  2014-11-10       Impact factor: 54.908

Review 9.  Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials.

Authors:  Yuru Vernon Shih; Shyni Varghese
Journal:  Biomaterials       Date:  2018-06-06       Impact factor: 12.479

10.  Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.

Authors:  Jessica A Cooke; Jason S Meyer
Journal:  Curr Ophthalmol Rep       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.